Sunday, November 15, 2015
Second of two parts
Over the past 20 years, the combined efforts of Congress, along with the offices of women’s health at FDA and NIH, have increased the participation of women in clinical trials. Minorities, however, still account for less than 5% of clinical trial participants. In fact, minorities “are not hard to reach; they are hardly reached” (Lu Chen, HealthDay News, March 2014).